<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26-pharmaceuticals-13-00233">
 <label>26.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sharma</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>T.E.</given-names>
   </name>
   <name>
    <surname>Moy</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Ceftazidime-Avibactam: A Novel Cephalosporin/Î²-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms</article-title>
  <source>Clin. Ther.</source>
  <year>2016</year>
  <volume>38</volume>
  <fpage>431</fpage>
  <lpage>444</lpage>
  <pub-id pub-id-type="doi">10.1016/j.clinthera.2016.01.018</pub-id>
  <pub-id pub-id-type="pmid">26948862</pub-id>
 </element-citation>
</ref>
